“…Practically water-insoluble (<0.1 mg/mL) chemicals have been estimated to make up ∼70% of the new drugs in development and ∼40% of the drugs established . The need for improving their bioavailability, though in competition with the stability, has spurred extensive research into more soluble phases, cocrystals, and dispersed morphologies. , While the surface-to-volume ratio , is an important factor, it is the polymorphism , that substantially determines the stability, crystal habit, solubility, and dissolution rate. The stable polymorph is favored by thermodynamics; yet, intermediate pathways can be more viable due to kinetics.…”